Full Paper
tively, and ratio images were generated directly from the red and
blue channels.
7.56–7.58 (t, 1H), 8.00–8.02 (d, 1H), 8.06–8.07 (d, 1H), 8.14–8.16 (d,
1H), 8.31–8.32 (d, 1H), 8.48–8.50 (d, 1H), 8.77 ppm (d, 1H);
13C NMR (150 MHz, DMSO): d=151.7, 129.7, 129.4, 128.9, 128.1,
123.9, 119.9, 119.4, 115.5, 73.7, 57.6, 56.5, 45.5, 40.8, 40.5, 19.0 ppm;
HRMS: m/z: calcd for C25H28N3O3S: 450.1846 [M+H]+; found:
450.1906.
For experiments of cellular localization, ventricular myocytes were
costained with 100 mm MQ-DS and 5.0 mm Lyso-Tracker DND-26 for
15 min at 378C. For confocal fluorescence images, MQ-DS was ex-
cited at l=405 nm and Lyso-Tracker DND-26 was excited at l=
488 nm; both were collected at l=505–520 nm.
Compound 5: 1,2-Dibromomethane (1.8684 g, 10.8 mmol) and 6-
methoxyquinoline (0.8586 g, 5.4 mmol) were mixed in DMF/PhMe
(3:2, 10 mL), and heated at 1308C for 12 h. After cooling to room
temperature, the mixture was filtered. The solid was washed sever-
al times with acetone. Compound 5 was obtained by centrifuga-
tion as a white solid (ꢁ65%).
For experiments of linearity between the fluorescence intensity
ratio and ClÀ concentrations, HepG2 cells were treated with Ty-
rode’s solution[13] (containing 136.9 mm potassium) containing vari-
ous concentrations of ClÀ, nigericin (5 mm), and tributyltin (10 mm)
for 30 min at 378C, and then incubated with MQ-DS (100 mm) for
15 min.
For cell images under various pH conditions, HepG2 cells were in-
cubated with universal buffer (pH 5.0 and 6.0; CClÀ =100 mm) for
1 h at 378C, then incubated with MQ-DS (100 mm) for 15 min.
Compound 6: Piperazine (0.5618 g, 6.5 mmol) and dansyl chloride
(0.1980 g, 5.4 mmol) were added to anhydrous methanol (10 mL),
and pyridine (0.5 mL) was used as a catalyst. The mixture was
stirred at 308C for 6 h under argon. The solution was purified by
column chromatography on silica gel, eluting with hexane/ethyl
acetate (3/1, v/v), to give 6 (ꢁ60%). HRMS: m/z calcd for
C16H21N3O2S: 320.1427 [M+H]+; found: 320.1331.
For experiments of myocardial ischemia, ventricular myocytes were
incubated with MQ-DS (100 mm) for 15 min at 378C, washed twice
with ischemic solution (sodium lactate instead of glucose from Ty-
rode’s solution), then imaged by using a confocal laser scanning
microscope every 15 min after adding the ischemic solution.
Zebrafish were incubated with 200 mm MQ-DS for 15 min, then
washed three times with water. The zebrafish were anesthetized
with 5% diethyl ether. After cutting of the tail (0 and 10 min), the
zebrafish were imaged by using a confocal laser scanning micro-
scope. The zebrafish were obtained from Biology Institute of
Shangdong Academy of Sciences. The experiments were approved
by the institutional committee. All the animal experiments were
carried out in accordance with the relevant laws and guidelines
issued by the Ethical Committee of Shangdong Academy of Scien-
ces.
Compound 2: Compound 6 (1.7280, 5.4 mmol) was dissolved in
anhydrous methanol (5 mL) and triethylamine (0.5 mL) was added
as a catalyst. The mixture was heated to 1208C and 5 (1.3500 g,
5.4 mmol) was added dropwise to the solution. After 6 h, a yellow
liquid was obtained. The crude product was purified by column
chromatography on silica gel, eluting with hexane/ethyl acetate/
methanol (1/3/0.2, v/v/v), to obtain probe 2 (ꢁ47%). 1H NMR
(600 MHz, CDCl3): d=2.02–2.06 (m, 4H), 2.89–2.92 (m, 6H), 4.10 (s,
2H), 7.08 (s, 1H), 7.21–7.23 (t, 1H), 7.33–7.36 (m, 2H), 7.54–7.56 (t,
2H), 7.93–7.96 (d, 1H), 8.12–8.13 (d, 1H), 8.19–8.20 (d, 1H), 8.40–
8.41 (d, 1H), 8.60–8.61 (d, 1H), 8.73 ppm (d, 1H); 13C NMR
(150 MHz, DMSO): d=159.3, 144.0, 143.0, 136.2, 130.6, 128.9, 126.6,
124.6, 123.4, 123.0, 122.7, 107.0, 56.53, 49.0, 40.8, 40.6, 31.1 ppm;
HRMS: m/z calcd for C27H31N4O3S: 491.2111 [M+H]+; found:
491.2754.
MTT assay
Ventricular myocytes (106 cellmLÀ1) were dispersed within replicate
96-well microtiter plates to a total volume of 200 mL per well.
Plates were maintained at 378C in a 5% CO2/95% air incubator for
24 h. Then ventricular myocytes were incubated for 16 h with dif-
ferent probe concentrations of 1.0ꢁ10À6, 1.0ꢁ10À5, 1.0ꢁ10À4, and
1.0ꢁ10À3 m. MTT solution (5 mgmLÀ1, phosphate-buffered saline
(PBS)) was then added to each well. After 4 h, the remaining MTT
solution was removed, and DMSO (150 mL) was added to each well
to dissolve the formazan crystals. Absorbance was measured at l=
490 nm in a Triturus microplate reader. Calculation of IC50 values
was performed according to the Huber and Koella method.[14]
Compounds 7 and 8: 4-Nitrobenzyl bromide (2.3331 g, 10.8 mmol)
was added to 6-methoxyquinoline (1.7172 g, 10.8 mmol) in DMF/
PhMe (3/2, 10 mL). The reaction temperature was kept at 1008C
for 6 h. The orange solution was obtained and filtered. Solid 7
(yield: ꢁ75%) was washed several times with acetone. The prod-
uct was dissolved in methanol and then Pd/C was added before H2
was introduced into the mixture. The solution was stirred at 508C
for 6 h and the solvent was removed on a rotary evaporator. Com-
pound 8 was obtained as a red solid (ꢁ60%). HRMS: m/z calcd for
C17H17N2O: 265.1335 [M+H]+; found: 265.1137.
Synthesis
Compound 4: 1,3-Dibromopropane (2.1708 g, 10.8 mmol) and 6-
methoxyquinoline (0.8586 g, 5.4 mmol) were dissolved in DMF/
PhMe (3:2, 10 mL) and heated at 1008C for 4 h. After cooling to
room temperature, the mixture was filtered. The solid was washed
several times with acetone. Compound 4 was collected by centrifu-
gation as an orange solid (ꢁ75%). HRMS m/z calcd for
C13H15BrNO: 280.0331 [M+H]+; found: 280.0328.
MQ-DS: Compound 8 (0.1315 g, 0.5 mmol) and dansyl chloride
(0.135 g, 0.5 mmol) were dissolved in anhydrous methanol (5 mL)
and pyridine (0.5 mL) was added as the catalyst. The mixture was
stirred at 1208C for 6 h under argon, and purified by column chro-
matography on silica gel, eluting with hexane/ethyl acetate (3:1,
1
v/v), to give MQ-DS (ꢁ60%). H NMR (600 MHz, CDCl3): d=2.87–
Compound 1: Dansylamide sodium salt (0.1360 g, 0.5 mmol) and 4
(0.2800 g, 1.0 mmol) were dissolved in DMF (8 mL), and heated at
808C for 24 h. An orange solution was obtained, which was puri-
fied by column chromatography on silica gel by eluting with
hexane/ethyl acetate/methanol (1/2/0.5, v/v/v) to give 1 (ꢁ50%).
1H NMR (600 MHz, CDCl3): d=1.99–2.02 (d, 2H), 2.21–2.23 (m, 2H),
2.87–2.89 (m, 6H), 3.87 (t, 3H), 4.29–4.36 (m, 2H), 4.79 (s, 1H), 7.08
(s, 1H), 7.16–7.19 (d, 1H), 7.38–7.40 (m, 2H), 7.41–7.44 (t, 1H),
2.89 (m, 6H), 3.87 (t, 3H), 4.29 (s, 2H), 4.82 (s, 1H), 6.92–6.93 (d,
2H),7.08–7.09 (d, 3H), 7.16–7.18 (d, 1H), 7.35–7.40 (m, 2H), 7.41–
7.43 (t, 1H), 7.53–7.56 (t, 1H), 8.00–8.02 (d, 1H), 8.06–8.07 (d, 1H),
8.16–8.17 (d, 1H), 8.34–8.35 (d, 1H), 8.48–8.49 (d, 1H), 8.77 ppm (d,
1H); 13C NMR (150 MHz, CDCl3): d=157.7, 152.1, 147.9, 144.3,
135.9, 135.0, 134.9, 134.2, 130.8, 130.3, 129.8, 129.6, 129.3, 128.6,
128.5, 123.1, 122.3, 121.4, 121.3, 118.5, 115.2, 105.1, 77.0, 76.8, 74.0,
58.0, 55.5, 45.4, 29.7 ppm; MS: m/z: 160.1, 371.1.
Chem. Eur. J. 2014, 20, 11760 – 11767
11766
ꢀ 2014 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim